Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. - Wikidata - awgldk - TriplyDB

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

http://www.wikidata.org/entity/Q34128479

about

Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients Infection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.Zinc-finger antiviral protein inhibits XMRV infection.Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells.Xenotropic murine leukemia virus-related virus in monozygotic twins discordant for chronic fatigue syndrome.Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer XMRV Discovery and Prostate Cancer-Related Research.The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.Discovery of drugs that possess activity against feline leukemia virus Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance.Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.Structural and functional insights into foamy viral integrase Detecting retroviral sequences in chronic fatigue syndrome.Suppression of HIV-1 Infectivity by Human Glioma Cells.Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.Differential sensitivities of retroviruses to integrase strand transfer inhibitors No evidence of XMRV infection in immunocompromised patients and HIV-positive individuals from Germany.

P2860

Q27674531-D588D852-D142-4FC7-997D-44C782B1420B Q28303254-D5E73B23-0B74-4D59-A0AC-E6FFCA8BF957 Q28304673-2FA37D3F-07BB-4C05-A468-38B4BF9DEF55 Q28729917-7FFE3A08-C0BB-459B-A0FD-DEAB8DE18DA2 Q30364549-50705588-DDE9-4691-8B25-063755F34083 Q34312227-27933E07-F8C8-4F90-BEB9-6D4AF5DFD4C9 Q35076674-A1ABBE37-B4C6-4C24-8052-795EF1C07E1B Q35172762-5EDBFA78-1BCE-4F97-9CAD-3A0D87615DB5 Q35633587-8819C3CB-F0D0-4C5F-A026-18FEC552914B Q35692325-0548EE7A-1469-4C17-A351-9D5B4887A31F Q35692335-4F9274AA-AB1E-48C1-941C-93D44F8D369D Q36290647-8A340294-0A44-4D8F-B5CD-5C09F37E48F3 Q36525355-E4146660-4A34-4C35-9D45-BF313AE5EC0C Q36760224-57022171-8912-46A6-9900-A10337EA02E1 Q36839676-5A0ECAB7-E050-4E59-9AD3-2E341FA58498 Q36917438-769348FA-B20B-4F70-913C-E7B48C89D7A1 Q37083728-83C7E4D0-9A94-4DE1-9DC5-1833D688EDFC Q38614212-E05A2614-B70B-49DA-AC51-B5A20FB25EF9 Q38813153-EB4DDE2E-17CA-4723-82A5-D3EF07670B91 Q41961457-25BCCD64-C209-4CC5-95A5-1EEA919613D2 Q42017701-D491C20E-882F-49CC-BB49-B8DAEFBAB4D9 Q54323114-A69ADCDA-F359-4E2B-BAB3-07BA31655856

P2860

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

http://www.wikidata.org/entity/Q34128479

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@ast

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@en

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@nl

type

label

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@ast

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@en

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@nl

prefLabel

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@ast

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@en

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

@nl

P1433

Q34128479-A3D09710-3203-4591-8D5B-1A72164A4D8D

P1476

Q34128479-8E5EC6BC-2C84-4277-9D08-0DF940D4E1F1

P2093

Q34128479-E1B5E62E-9921-434A-84D0-2C73C28C691C

P2860

Q34128479-034AC606-8CA4-4BD6-B0A4-2AC3A8ED8305

Q34128479-058F81AA-0850-4C51-A4B4-D9C654AAD9F2

Q34128479-0931F75F-17AB-4146-B001-A8D98B968737

Q34128479-0E785CDA-371C-4BDF-88E5-B5486581D610

Q34128479-10FA908C-9103-47BA-BAA2-CDABBC201209

Q34128479-14364C78-6C1A-4F44-BEF0-0A56522C2965

Q34128479-1B24849A-6781-41ED-808A-C45403DCF2D4

Q34128479-2293AC15-2E93-48C8-A88B-767077CD4092

Q34128479-23713774-8822-4013-8147-4FC3F5A5154A

Q34128479-239110B6-C2AC-4BBE-98C2-82E268C88E0F

P2888

Q34128479-1CF35AFF-F8FC-4248-8AE9-4F5D5DD00207

P304

Q34128479-66AFB563-9BCA-4D77-890E-13023C967BCB

P31

Q34128479-00AD8D4B-8AE1-49EC-93FE-AA4A477F9E6D

P356

Q34128479-FEDE590B-1B84-46EC-9DDC-8C5B20C1429B

P478

Q34128479-C7FEC3A7-3DF3-4538-AA04-4CB05B0606C7

P50

Q34128479-51577C4B-79F5-4EFF-AAE7-32B5017396D4

Q34128479-CCEAB08A-7EB6-4225-8DAF-43DF2C14A2E2

P577

Q34128479-9201D102-F831-4D6B-8DEF-D63B21ABEBAD

P5875

Q34128479-121144EE-74C4-4129-82EC-05267AFDDDF2

P6179

Q34128479-A60954E1-7768-4834-A29A-7CE690BBE28B

P698

Q34128479-42A5491D-C6AD-457A-B3FB-62C05405EB26

P921

Q34128479-B1538159-8B13-4390-97A4-B890976ABE1B

P932

Q34128479-82698289-6656-43F5-98CE-0478F7ACB8DD

P356

P1433

P1476

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors

@en

P2093

Robert A Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome

Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients

A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction

Retroviral intasome assembly and inhibition of DNA strand transfer

Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort

Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase

Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer

P2888

P304

70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-7-70

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey S. Gottlieb

A. Dusty Miller, Arthur G. Miller

P577

2010-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46107183

http://www.w3.org/2001/XMLSchema#string

P6179

1041908980

http://www.w3.org/2001/XMLSchema#string

P698

20807431

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2939604

http://www.w3.org/2001/XMLSchema#string